Paper6371017
Chemotherapy in advanced ovarian cancer.
Rodenburg CJ and 1 other. J Cancer Res Clin Oncol, 1984. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Chemotherapy in advanced ovarian cancer. Papers, record 6371017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6371017
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Ovarian Neoplasms | Major topic |
| Alkylating Agents | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Injections, Intraperitoneal | |
| Neoplasm Staging | |
| Prognosis | |
| Random Allocation | |
| Time Factors |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 175277 | Management of ovarian carcinoma. Current concepts and future prospects. | N Engl J Med | 1976 | https://conductscience.org/library/papers/175277 | PubMed |
| 2 | 6131277 | JMS, successor to cisplatin in advanced ovarian carcinoma? | Lancet | 1983 | https://conductscience.org/library/papers/6131277 | PubMed |
| 3 | 406560 | Acute leukemia after alkylating-agent therapy of ovarian cancer. | N Engl J Med | 1977 | https://conductscience.org/library/papers/406560 | PubMed |
| 4 | 6752720 | Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. | N Engl J Med | 1982 | https://conductscience.org/library/papers/6752720 | PubMed |
| 5 | 7471076 | Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. | Cancer Res | 1980 | https://conductscience.org/library/papers/7471076 | PubMed |
| 6 | 7378989 | Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin. | Cancer | 1980 | https://conductscience.org/library/papers/7378989 | PubMed |
| 7 | 110083 | Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics. | AJR Am J Roentgenol | 1979 | https://conductscience.org/library/papers/110083 | PubMed |
| 8 | 6787963 | Epithelial carcinoma of the ovary: current strategies. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/6787963 | PubMed |
| 9 | 5892067 | The role of chemotherapy in the treatment of gynecologic malignancy. | Am J Obstet Gynecol | 1965 | https://conductscience.org/library/papers/5892067 | PubMed |
| 10 | 7105021 | Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. | Cancer Res | 1982 | https://conductscience.org/library/papers/7105021 | PubMed |
| 11 | 6796106 | Medical Research Council study on chemotherapy in advanced ovarian cancer. Medical Research Council's Working Party on ovarian cancer. | Br J Obstet Gynaecol | 1981 | https://conductscience.org/library/papers/6796106 | PubMed |
| 12 | 6681730 | Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. | Cancer Res | 1983 | https://conductscience.org/library/papers/6681730 | PubMed |
| 13 | 101843 | Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. | N Engl J Med | 1978 | https://conductscience.org/library/papers/101843 | PubMed |
| 14 | 6258537 | Surgical management of ovarian cancer. | Arch Surg | 1981 | https://conductscience.org/library/papers/6258537 | PubMed |
| 15 | 107464 | Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future. | Neth J Med | 1979 | https://conductscience.org/library/papers/107464 | PubMed |
| 16 | 6110955 | Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma. | Lancet | 1981 | https://conductscience.org/library/papers/6110955 | PubMed |
| 17 | 6890785 | Intraperitoneal cisplatin with systemic thiosulfate protection. | Ann Intern Med | 1982 | https://conductscience.org/library/papers/6890785 | PubMed |
| 18 | 219695 | Hexamethylmelamine: an evaluation of its role in the treatment of ovarian cancer. | Am J Obstet Gynecol | 1979 | https://conductscience.org/library/papers/219695 | PubMed |
| 19 | 4962186 | Chemotherapy of ovarian cancer. | Int Surg | 1967 | https://conductscience.org/library/papers/4962186 | PubMed |
| 20 | 445503 | Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/445503 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 19487811 | Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19487811 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6371017
GET https://conductscience.org/api/papers/v1/6371017/references?page=2